Literature DB >> 21297611

A MRSA-terious enemy among us: boosting MRSA vaccines.

Scott D Kobayashi1, Frank R DeLeo.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21297611     DOI： 10.1038/nm0211-168

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  16 in total

1.  Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans.

Authors:  Clayton Harro; Robert Betts; Walter Orenstein; Eun-Jeong Kwak; Howard E Greenberg; Matthew T Onorato; Jon Hartzel; Joy Lipka; Mark J DiNubile; Nicholas Kartsonis
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

2.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 3.  Staphylococcal vaccines and immunotherapy: to dream the impossible dream?

Authors:  Steven J Projan; Mirjana Nesin; Paul M Dunman
Journal:  Curr Opin Pharmacol       Date:  2006-07-25       Impact factor: 5.547

4.  Whither antibacterial drug discovery?

Authors:  Steven J Projan
Journal:  Drug Discov Today       Date:  2008-04       Impact factor: 7.851

5.  IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge.

Authors:  Hwan Keun Kim; Andrea DeDent; Alice G Cheng; Molly McAdow; Fabio Bagnoli; Dominique M Missiakas; Olaf Schneewind
Journal:  Vaccine       Date:  2010-03-10       Impact factor: 3.641

6.  A new view on development of a Staphylococcus aureus vaccine: insights from mice and men.

Authors:  Brad Spellberg; Robert Daum
Journal:  Hum Vaccin       Date:  2010-10-01

7.  Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.

Authors:  Simon R Clarke; Kirsten J Brummell; Malcolm J Horsburgh; Philip W McDowell; Sharifah A Syed Mohamad; Melanie R Stapleton; Jorge Acevedo; Robert C Read; Nicholas P J Day; Sharon J Peacock; James J Mond; John F Kokai-Kun; Simon J Foster
Journal:  J Infect Dis       Date:  2006-03-13       Impact factor: 5.226

8.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

Review 9.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

10.  Vaccine protection against Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Olaf Schneewind
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307
View more
  7 in total

1.  Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio- protective Mn2+-Peptide complex from Deinococcus.

Authors:  Elena K Gaidamakova; Ian A Myles; Dennis P McDaniel; Sandip K Datta; Michael J Daly; Cedar J Fowler; Patricia A Valdez; Shruti Naik; Manoshi Gayen; Paridhi Gupta; Anuj Sharma; Pamela J Glass; Radha K Maheshwari
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

Review 2.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

Review 3.  Innate and adaptive immune responses against Staphylococcus aureus skin infections.

Authors:  Sheila Krishna; Lloyd S Miller
Journal:  Semin Immunopathol       Date:  2011-11-06       Impact factor: 9.623

4.  Phagocytosis and killing of Staphylococcus aureus by human neutrophils.

Authors:  Thea Lu; Adeline R Porter; Adam D Kennedy; Scott D Kobayashi; Frank R DeLeo
Journal:  J Innate Immun       Date:  2014-04-05       Impact factor: 7.349

Review 5.  Immunity against Staphylococcus aureus cutaneous infections.

Authors:  Lloyd S Miller; John S Cho
Journal:  Nat Rev Immunol       Date:  2011-07-01       Impact factor: 53.106

6.  Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus.

Authors:  Brian T Tsuji; Tanya Brown; Ridhi Parasrampuria; Daniel A Brazeau; Alan Forrest; Pamela A Kelchlin; Patricia N Holden; Charles A Peloquin; Debra Hanna; Jurgen B Bulitta
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

7.  Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb.

Authors:  Maria Georgoutsou-Spyridonos; Daniel Ricklin; Haris Pratsinis; Eustathia Perivolioti; Ioannis Pirmettis; Brandon L Garcia; Brian V Geisbrecht; Periklis G Foukas; John D Lambris; Dimitrios C Mastellos; Georgia Sfyroera
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.